Richard E. Rupp

4.3k citations
107 papers · 3.3k · 1 hit paper · h-index 28

Impact in

  • Infectious Diseases top 2%
    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
  • Health top 2%
    • Vaccine Coverage and Hesitancy

Papers in

  • Epidemiology 47
    • Cervical Cancer and HPV Research 21
    • Hepatitis B Virus Studies 10
    • Herpesvirus Infections and Treatments 10
    • Influenza Virus Research Studies 9
    • Cytomegalovirus and herpesvirus research 9
  • Health 17
    • Vaccine Coverage and Hesitancy 17
Co-authors
Susan L. Rosenthal (14 shared papers)Lawrence Raymond Stanberry (6 shared papers)Abbey B. Berenson (17 shared papers)Jacqueline M. Hirth (15 shared papers)Christine B. Turley (3 shared papers)Kemet D. Spence (3 shared papers)Gregory D. Zimet (3 shared papers)Mary B. Short (5 shared papers)
Journals
Vaccine (15 papers)The Journal of Infectious Diseases (8 papers)Human Vaccines & Immunotherapeutics (8 papers)npj Vaccines (5 papers)Journal of Adolescent Health (4 papers)
Partner nations
United StatesUnited KingdomAustralia

In The Last Decade

Richard E. Rupp

100 papers receiving 3.1k citations

Richard E. Rupp's Hit Papers

Homologous and Heterologous Covid-19 Booster Vaccinations 2022 · 442 citations
4420+1+2Years since publication100200300400
What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

  1. 2022 New England Journal of Medicine

Peers

Richard E. Rupp
Comparison fields: 5 of 137
  • Infectious Diseases 1.0k
  • Health 366
  • Epidemiology 1.4k
  • Microbiology 152
  • Immunology 425
Replace Gregory A. Poland with:
Gregory A. Poland United States
Carol J. Hickman United States
Gregory S. Wallace United States
Alberto Severini Canada
Susan B. Redd United States
Ting Wu China
Heather M. Scobie United States
Jennifer S. Rota United States
John Witte, Jr. United States
Glenda L. Lawrence Australia
Richard E. Rupp relative to Gregory A. Poland United States Gregory A. Poland's profile →
Citations per field
00.5×2×4×5.7×
Gregory A. Poland · 1×
Citations per year

Countries citing papers authored by Richard E. Rupp

Since Specialization
Citations

This map shows the geographic impact of Richard E. Rupp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Rupp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Rupp more than expected).

Fields of papers citing papers by Richard E. Rupp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Rupp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Rupp. The network helps show where Richard E. Rupp may publish in the future.

Co-authors

The 25 scholars most cited alongside Richard E. Rupp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard E. Rupp Line = papers co-authored together Richard E. Rupp links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Homologous and Heterologous Covid-19 Booster Vaccinations
New England Journal of Medicine ·Robert L. Atmar, Kirsten E. Lyke, Meagan E. Deming, Lisa A. Jackson, Angela R Branche, Hana M. El Sahly, Christina A. Rostad, Judith M. Martin
Hit paper breakdown →		2022442
2
Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults
Vaccine ·Christine B. Turley, Richard E. Rupp, Casey Johnson, David C. Taylor, Julie Anna Wolfson, Lynda Tussey, Uma Kavita, Lawrence Raymond Stanberry
2011265
3
VivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infection.
PubMed ·Richard E. Rupp, Susan L. Rosenthal, Lawrence Raymond Stanberry
2007210
4
Uptake of HPV Vaccine: Demographics, Sexual History and Values, Parenting Style, and Vaccine Attitudes
Journal of Adolescent Health ·Susan L. Rosenthal, Richard E. Rupp, Gregory D. Zimet, Heather M. Meza, Melissa L. Loza, Mary B. Short, Paul Succop
2008189
5
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial
Vaccine ·David I. Bernstein, Flor M. Muñoz, S. Todd Callahan, Richard E. Rupp, Susan H. Wootton, Kathryn M. Edwards, Christine B. Turley, Lawrence Raymond Stanberry
2015186
6
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
Cell Reports Medicine ·Kirsten E. Lyke, Robert L. Atmar, Clara Penelope Dominguez Islas, Christine M. Posavad, Daniel W. Szydlo, Rahul Paul Chourdhury, Meagan E. Deming, Amanda Eaton
2022126
7
Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use With MF59 Adjuvant
JAMA ·Mark J. Mulligan, David I. Bernstein, Patricia L. Winokur, Richard E. Rupp, Evan J. Anderson, Nadine Rouphael, Michelle Dickey, Jack T. Stapleton
2014119
8
Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults
The Journal of Infectious Diseases ·Scott A. Halperin, José Ramón Arribas, Richard E. Rupp, Charles P. Andrews, Laurence Chu, Rituparna Das, Jakub K. Simon, Matthew T. Onorato
201766
9
A bacterial-induced lectin which triggers hemocyte coagulation in Manducasexta
Biochemical and Biophysical Research Communications ·Michael F. Minnick, Richard E. Rupp, Kemet D. Spence
198666
10
Factors Associated With Completion of the Human Papillomavirus Vaccine Series
Clinical Pediatrics ·Tara Neubrand, Carmen Radecki Breitkopf, Richard E. Rupp, Daniel M. Breitkopf, Susan L. Rosenthal
200965
11
Effect of Climate on the Distribution of Fusarium spp. Causing Crown Rot of Wheat in the Pacific Northwest of the United States
Phytopathology ·Grant J. Poole, Richard W. Smiley, Carl Walker, David R. Huggins, Richard E. Rupp, John T. Abatzoglou, Kim Campbell, Timothy C. Paulitz
201363
12
Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects
The Journal of Infectious Diseases ·Stuart P. Adler, Nicole M. Lewis, Anthony Conlon, Mark P. Christiansen, Mohamed S Al-Ibrahim, Richard E. Rupp, Tong‐Ming Fu, Oliver M Bautista
201962
13
Maternal and infant outcomes among women vaccinated against pertussis during pregnancy
Human Vaccines & Immunotherapeutics ·Abbey B. Berenson, Jacqueline M. Hirth, Mahbubur Rahman, Tabassum Haque Laz, Richard E. Rupp, Kwabena O. Sarpong
201658
14
Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study
Vaccine ·Richard E. Rupp, Gary J. Luckasen, Judith Lee Kirstein, Jorge E. Osorio, Joseph D. Santangelo, Marsha Gold Raanan, Derek J. Wallace, Gilad Shalag Gordon
201556
15
A brief educational intervention increases providers' human papillomavirus vaccine knowledge
Human Vaccines & Immunotherapeutics ·Abbey B. Berenson, Mahbubur Rahman, Jacqueline M. Hirth, Richard E. Rupp, Kwabena O. Sarpong
201550
16
Ethnic and Gender Disparities in Needed Adolescent Mental Health Care
Journal of Health Care for the Poor and Underserved ·John F. Thomas, Jeff R. Temple, Noe Perez, Richard E. Rupp
201144
17
Potential oversummering and overwintering regions for the wheat stripe rust pathogen in the contiguous United States
International Journal of Biometeorology ·Dipak Sharma‐Poudyal, Xianming Chen, Richard E. Rupp
201344
18
A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate
Vaccine ·Lisa A. Jackson, Richard E. Rupp, Athanasia Papadimitriou, Derek J. Wallace, Marsha Gold Raanan, Kelley J. Moss
201839
19
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age
Vaccine ·Susan J. Ermlich, Charles P. Andrews, Steven Folkerth, Richard E. Rupp, David Greenberg, Richard D. McFetridge, Jonathan S. Hartzel, Rocio D. Marchese
201838
20
School-based HPV immunization of young adolescents: Effects of two brief health interventions
Human Vaccines & Immunotherapeutics ·Vaughn I. Rickert, Beth A. Auslander, Dena Saliagas Cox, Susan L. Rosenthal, Richard E. Rupp, Gregory D. Zimet
201537

About Richard E. Rupp

Richard E. Rupp is a scholar working on Epidemiology, Health, Infectious Diseases, Microbiology and Immunology, having authored 107 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (21 papers), Vaccine Coverage and Hesitancy (17 papers), SARS-CoV-2 and COVID-19 Research (16 papers), Hepatitis B Virus Studies (10 papers), Herpesvirus Infections and Treatments (10 papers), Influenza Virus Research Studies (9 papers), Cytomegalovirus and herpesvirus research (9 papers) and Mosquito-borne diseases and control (6 papers). The work is most often cited by research in Infectious Diseases (1.0k citations), Health (366 citations), Epidemiology (1.4k citations), Microbiology (152 citations) and Immunology (425 citations). Richard E. Rupp has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Susan L. Rosenthal, Lawrence Raymond Stanberry, Abbey B. Berenson, Jacqueline M. Hirth, Christine B. Turley, Kemet D. Spence, Gregory D. Zimet, Mary B. Short, David I. Bernstein and Lynda Tussey. Their work appears in journals such as Vaccine, The Journal of Infectious Diseases, Human Vaccines & Immunotherapeutics, npj Vaccines and Journal of Adolescent Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory A. PolandBreakdown of academic impact, for papers by Carol J. HickmanBreakdown of academic impact, for papers by Gregory S. WallaceBreakdown of academic impact, for papers by Alberto SeveriniBreakdown of academic impact, for papers by Susan B. ReddBreakdown of academic impact, for papers by Ting WuBreakdown of academic impact, for papers by Heather M. ScobieBreakdown of academic impact, for papers by Jennifer S. RotaBreakdown of academic impact, for papers by John Witte, Jr.Breakdown of academic impact, for papers by Glenda L. Lawrence